CD8A and lymphoma: This study also showed that the NK and T CD8+ cells were involved in the lymphomagenesis inhibition, since the in vivo depletion of NK-cells with an antibody or the engraftment of CD8-depleted PBMCs resulted in the appearance of lymphomas in 100% and 75% of the engrafted mice, respectively.